Targeting the AMP-Activated Protein Kinase for the Treatment of Type 2 Diabetes

E-ISSN： 1875-5917|2|2|119-127

ISSN： 1568-0088

Source： Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol.2, Iss.2, 2002-07, pp. : 119-127

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

AMP-Activated Protein Kinase and Type 2 Diabetes

Current Medicinal Chemistry, Vol. 13, Iss. 5, 2006-03 ,pp. : 583-589

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the liver kinase B1/AMP-activated protein kinase pathway as a therapeutic strategy for hematological malignancies

By Martelli Alberto M Chiarini Francesca Evangelisti Camilla Ognibene Andrea Bressanin Daniela Billi Anna Maria Manzoli Lucia Cappellini Alessandra McCubrey James A

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 7, 2012-07 ,pp. : 729-742

Informa Healthcare

Access to resources Recommend Favorite

Prolonged AMP-activated protein kinase induction impairs vascular functions

By Ertuna Elif

Canadian Journal of Physiology and Pharmacology, Vol. 91, Iss. 12, 2013-01 ,pp. : 1025-1030

NRC Research Press

Access to resources Recommend Favorite

AMP-activated protein kinase — the fat controller of the energy railroad

By Steinberg Gregory R. Macaulay S. L. Febbraio Mark A Kemp Bruce E.

Canadian Journal of Physiology and Pharmacology, Vol. 84, Iss. 7, 2006-07 ,pp. : 655-665

NRC Research Press

Access to resources Recommend Favorite

Exploiting the anti-inflammatory effects of AMP-activated protein kinase activation

By Salt Ian P Palmer Timothy M

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 8, 2012-08 ,pp. : 1155-1167

Informa Healthcare

Access to resources Recommend Favorite